SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-145073"
 

Search: onr:"swepub:oai:DiVA.org:liu-145073" > PlGF-induced VEGFR1...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Iwamoto, HidekiKarolinska Inst, Sweden (author)

PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors

  • Article/chapterEnglish2015

Publisher, publication year, extent ...

  • AMER ASSOC ADVANCEMENT SCIENCE,2015
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-145073
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-145073URI
  • https://doi.org/10.1126/sciadv.1400244DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:136560524URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Swedish Research Council; Swedish Cancer Foundation; Karolinska Institute Foundation; Karolinska Institute distinguished professor award; Torsten Soderberg Foundation; European Research Council (ERC) [250021]; NOVO Nordisk Foundation; Royal Alice Wallenberg Foundation; International Research Fund for Subsidy of Kyushu University School of Medicine Alumni
  • Inhibition of Dll4 (delta-like ligand 4)-Notch signaling-mediated tumor angiogenesis is an attractive approach in cancer therapy. However, inhibition of Dll4-Notch signaling has produced different effects in various tumors, and no biomarkers are available for predicting the anti-Dll4-Notch-associated antitumor activity. We show that human and mouse tumor cell-derived placental growth factor (PlGF) is a key determinant of the Dll4-Notch-induced vascular remodeling and tumor growth. In natural PlGF-expressing human tumors, inhibition of Dll4-Notch signaling markedly accelerated tumor growth by increasing blood perfusion in nonleaking tumor vasculatures. Conversely, in PlGF-negative tumors, Dll4 inhibition suppressed tumor growth by the formation of nonproductive and leaky vessels. Surprisingly, genetic inactivation of vascular endothelial growth factor receptor 1 (VEGFR1) completely abrogated the PlGF-modulated vascular remodeling and tumor growth, indicating a crucial role for VEGFR1-mediated signals in modulating Dll4-Notch functions. These findings provide mechanistic insights on PlGF-VEGFR1 signaling in the modulation of the Dll4-Notch pathway in angiogenesis and tumor growth, and have therapeutic implications of PlGF as a biomarker for predicting the antitumor benefits of Dll4 and Notch inhibitors.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Zhang, YinKarolinska Institutet,Karolinska Inst, Sweden (author)
  • Seki, TakahiroKarolinska Institutet,Karolinska Inst, Sweden (author)
  • Yang, YunlongKarolinska Institutet,Karolinska Inst, Sweden (author)
  • Nakamura, MasakiKarolinska Institutet,Karolinska Inst, Sweden (author)
  • Wang, JianKarolinska Inst, Sweden (author)
  • Yang, XiaojuanKarolinska Inst, Sweden; Tongji Univ, Peoples R China (author)
  • Torimura, TakujiKurume Univ, Japan (author)
  • Cao, YihaiLinköpings universitet,Institutionen för medicin och hälsa,Medicinska fakulteten,Karolinska Inst, Sweden; Univ Leicester, England; Glenfield Hosp, England(Swepub:liu)yihca64 (author)
  • Karolinska InstitutetKarolinska Inst, Sweden (creator_code:org_t)

Related titles

  • In:Science Advances: AMER ASSOC ADVANCEMENT SCIENCE1:32375-2548

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view